Treatment After Ruxolitinib Failure in MPN

Treatments being studied after primary ruxolitinib failure, suboptimal ruxolitinib response, and secondary ruxolitinib failure, are discussed. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/